BioSpace News Archive

MellingMedical, a leading provider of medical supplies, equipment, devices and pharmaceuticals to federal health facilities across the country under the VA’s “Veterans First” procurement program, today announced a vital distribution relationship with Katena Products, a recognized worldwide leader in specialty surgical and consumable ophthalmic and optometric products.

The Oklahoma Mesothelioma Victims Center says, “We are urging an oil refinery or oil and gas field worker who has recently been diagnosed with mesothelioma or asbestos exposure lung cancer anywhere in Oklahoma to call us anytime at 800-714-0303 to ensure they have direct access to Erik Karst, founding partner of Karst von Oiste.

The US Navy Veterans Mesothelioma Advocate says, “We don’t want one US Navy Veteran with confirmed mesothelioma to torpedo their chances of getting the best possible financial compensation settlement because they hired a less-than-qualified law firm or lawyer, or because they called about a free generic book about mesothelioma.

Spheryx, Inc. announces the demonstration of its new particle characterization instrument, xSight, at PepTalk: The Protein Science Week in the Exhibit Hall, Booth 613, at the San Diego Hilton Bayfront, San Diego

Integrated network matches at-risk Washingtonians with personalized prevention program

FACIT, a business accelerator for Ontario oncology innovations, announced a follow-on investment in Toronto-based start-up DNAstack.

SpendEdge has announced the completion of their latest inventory management system for a pharmaceutical supplier.

Record Number of Calls to the Colorado Child Abuse & Neglect Hotline 1-844-CO-4-KIDS in 2018

The latest techniques to prevent postoperative delirium will be the focus as global experts will form a distinguished panel at the upcoming World Patient Safety, Science & Technology Summit

LifeMap Sciences, Inc., a subsidiary of AgeX Therapeutics, Inc. (NYSE American: AGE) announced today that Tianjin Novogene Medical Laboratory, LifeMap, and Shanghai Shanyi today announced a partnership to provide a combined, best-of-breed Clinical NGS analysis and interpretation platform for Tianjin Novogene Medical Laboratory’s customers in China.